MD HB1121 | 2024 | Regular Session
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 7 2024 - 25% progression, died in committee
Action: 2024-02-14 - Hearing 3/01 at 2:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 7 2024 - 25% progression, died in committee
Action: 2024-02-14 - Hearing 3/01 at 2:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring a licensed health care provider who prescribes or dispenses an opioid or an opioid overdose reversal drug, to provide certain information to the individual receiving the prescription; and authorizing a pharmacist to comply with the requirement by posting the information in a conspicuous location.
Title
Public Health - Opioids and Opioid Overdose Reversal Drugs - Information
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-02-14 | House | Hearing 3/01 at 2:00 p.m. |
2024-02-07 | House | First Reading Health and Government Operations |
Subjects
Disclosure
Health
Health Occupations
Notices
Opioids
Pharmacists and Pharmacies
Public Health
Safety
Substance Abuse
Substance Abuse Treatment
Health
Health Occupations
Notices
Opioids
Pharmacists and Pharmacies
Public Health
Safety
Substance Abuse
Substance Abuse Treatment
Code Citations
Chapter | Article | Section | Citation Type | Statute Text |
---|---|---|---|---|
Health - General | 13 | 35A-01 | (n/a) | See Bill Text |
Health - General | 13 | 35A-02 | (n/a) | See Bill Text |
Maryland State Sources
Type | Source |
---|---|
Summary | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1121?ys=2024RS |
Text | https://mgaleg.maryland.gov/2024RS/bills/hb/hb1121f.pdf |